Director Precision Medicine, Labs & Societies

At AstraZeneca, we are redefining cancer care through precision medicine—ensuring the right patients receive the right therapies at the right time. This role sits at the center of that ambition, crafting how diagnostic ecosystems evolve to support our oncology portfolio today and into the future.

We are seeking a senior, enterprise-minded leader to define and drive AstraZeneca’s national laboratory and oncology society engagement strategy, translating scientific innovation into scalable, real-world patient impact.

This position reports to the Senior Director, Precision Medicine, and Marketing, and partners broadly across commercial, market access, medical affairs, and alliance organizations.

The Opportunity

As Director, National Labs & Societies, you will lead the strategy and execution of AstraZeneca’s engagement with national laboratory networks and key oncology societies, ensuring optimal integration of companion diagnostics into clinical practice.

You will operate at the intersection of commercial strategy, market access, and scientific engagement, influencing how biomarker testing is adopted, reimbursed, and operationalized across the U.S. oncology ecosystem.

This is a high-impact role with visible enterprise influence, shaping diagnostic strategy across multiple brands and indications while directly contributing to improved patient identification and access.

Key Responsibilities

Enterprise Leadership in Companion Diagnostics & Lab Strategy

• Define and lead AstraZeneca’s U.S. national lab strategy, including prioritization, partnership models, and long-term ecosystem evolution
• Serve as the primary strategic collaborate with leading national lab organizations, driving alignment on testing practices, data exchange, and innovation
• Anticipate shifts in diagnostic technologies, reimbursement, and lab consolidation—and proactive position AstraZeneca to lead.

Driving Measurable Patient Impact

• Establish and deliver against clear performance metrics, including biomarker testing adoption, time-to-test optimization, and patient identification rates
• Translate diagnostic strategy into actionable plans that improve end-to-end patient journey outcomes

Commercial & Market Access Integration

• Partner closely with Market Access, HEOR, and brand teams to align diagnostic strategy with payer dynamics and coverage pathways
• Shape approaches that address access barriers to testing, including reimbursement, coding, and lab workflow considerations
• Build strong, compliant partnerships with laboratories that help bring innovative diagnostic testing into routine oncology care

Strategic Partnerships & External Engagement

• Build and expand relationships with leading national laboratories, diagnostic companies, and oncology societies
• Represent AstraZeneca in external scientific and industry forums, influencing standards of care and diagnostic guidelines
• Identify and advance opportunities for innovative collaborations across the diagnostic ecosystem

Insight Generation & Data-Driven Strategy

• Lead integration of lab, market, and customer insights into actionable strategies
• Translate insights into brand, access, and precision medicine initiatives that drive impact
• Elevate emerging trends and barriers to senior leadership with clear recommendations

Cross-Functional Leadership

• Act as a strategic connector across Precision Medicine, Marketing, Sales, Medical Affairs, and Market Access
• Influence without authority to ensure aligned execution across a complex matrix organization
• Mentor team members on evolving diagnostic and lab dynamics

Key Milestones

• Measurable increases in biomarker testing and appropriate patient identification
• Strong, strategic partnerships established with top-tier national labs and oncology societies
• Diagnostic strategies fully integrated into brand and market access planning
• Demonstrated influence on testing practices and standards of care in priority indications

Essential Qualifications

• Bachelor’s degree required
• 10+ years of experience in pharma, biotech, or healthcare, including at least 5 years in oncology, diagnostics, or precision medicine
• Demonstrated leader Established relationships within the U.S. oncology ecosystem ship in cross-functional strategy development and execution within complex, matrixed organizations
• Proven ability to influence senior collaborators across commercial, medical, and market access functions, as well as external partners
• Strong critical thinkin